The trends affecting the biopharma industry that we’ve evaluated over the past decade have remained relatively stable. In this highly regulated healthcare industry segment, decision-makers often consider adoption of novel ... read more

Biosimilars are continuing to change the biopharmaceutical industry. Some biosimilars and biogeneric products have already entered world markets, and the rather full development pipeline1 means many more are coming, along ... read more

Biopharmaceutical manufacturing directly supports the $240 billion biologics industry, and small improvements in costs of manufacturing can result in very significant savings. However, unlike other industries, where adoption ... read more

Fill and finish operations over the past 25+ years have remained relatively stable in terms of technology, capacity, and competitive environment. However, over the past few years, this important area has rapidly gained ... read more